Actively Recruiting
Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IB3,IIA2)
Led by Obstetrics & Gynecology Hospital of Fudan University · Updated on 2021-11-10
1104
Participants Needed
1
Research Sites
263 weeks
Total Duration
On this page
Sponsors
O
Obstetrics & Gynecology Hospital of Fudan University
Lead Sponsor
C
Children's Hospital of Fudan University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to confirm whether there is a difference between laparoscopic radical hysterectomy (LRH) and abdominal radical hysterectomy (ARH) in patient survival for Cervical Cancer (Stage IB3, IIA2).
CONDITIONS
Official Title
Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IB3,IIA2)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical diagnosis of squamous carcinoma of the cervix, adenocarcinoma, or squamous adenocarcinoma at Stage IB3 or IIA2
- Age between 21 and 70 years
- Eligible for surgery type B or C according to Q-M surgical staging
- Normal liver and kidney function and blood counts within specified limits
- Hemoglobin greater than 60 g/L
- Platelet count greater than 70 x 10^9/L
- Leukocyte count greater than 3 x 10^9/L
- Creatinine less than 50 mg/dL
- Transaminase levels not more than three times the upper normal limit
- No history of other malignancies
- Not pregnant
- Karnofsky performance score of 60 or higher
- Voluntary participation with signed informed consent and willingness to comply with follow-up
- No psychiatric disorders or serious immune system disorders such as lupus erythematosus, myasthenia gravis, or HIV infection
You will not qualify if you...
- Contraindications for surgery that prevent undergoing the procedure
- Prior pelvic or abdominal radiotherapy or neoadjuvant chemotherapy for cervical cancer
- Recurrent cervical cancer
- Imaging (CT, MRI, or PET-CT) showing suspicious pelvic lymph node metastasis with maximum diameter greater than 2 cm after preoperative evaluation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Obstetrics and Gynecology Hospital of Fudan University
Shanghai, Shanghai Municipality, China, 200000
Actively Recruiting
Research Team
H
Hua Jiang, PHD
CONTACT
X
Xin Wu, PHD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here